University of Heidelberg
BIOQUANT

Student talks

International meetings

  • K. Börner, E. Kienle, A. Sacher, M. Müller, H.-G. Kräusslich & D. Grimm. "Peptide-mediated retargeting of 12 AAV serotypes". Annual meeting of the European Society of Gene & Cell Therapy (ESGCT). Madrid, Spain, 2013.
  • K. Börner, D. Niopek, D. Gilbert, K. Streetz, H.-G. Kräusslich & D. Grimm. "Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors or cell lines". Annual meeting of the European Society of Gene & Cell Therapy (ESGCT). Madrid, Spain, 2013.
  • K. Börner, E. Kienle, A. Sacher, M. Müller, H.-G. Kräusslich & D. Grimm. "Peptide-mediated retargeting of 13 AAV serotypes". International Symposium on Synthetic Biology. Heidelberg, Germany, 2013.
  • E. Senis & D. Grimm. "Engineering of an endogenous miRNA locus as a novel strategy for controlled expression of therapeutic shRNAs". International Symposium on Synthetic Biology. Heidelberg, Germany, 2013.
  • T. Michler, U. Protzer & D. Grimm. "Enhancing safety and efficacy of RNAi-based gene therapy for the treatment of chronic hepatitis B". International Symposium on Synthetic Biology. Heidelberg, Germany, 2013.
  • K. Börner, D. Niopek, D. Gilbert, K. Streetz, H.-G. Kräusslich & D. Grimm. "Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors or cell lines". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Salt Lake City (UT), USA, 2013. (Travel award)
  • N. Schürmann, L. Trabuco, C. Bender, R. Russell & D. Grimm. "Directed evolution-based dissection of the four human Argonaute proteins". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Salt Lake City (UT), USA, 2013.
  • C. Hammerschmidt-Kamper, F. Hentzschel, K. Heiss, K. Börner, A.-K. Müller & D. Grimm. "AAV/RNAi-mediated improvement of anti-malaria vaccination strategies". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Salt Lake City (UT), USA, 2013.
  • E. Senis & D. Grimm. "An AAV vector toolbox for iPS cell reprogramming and purging". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT), Philadelphia (PA), USA, 2012. (Travel award)
  • K. Börner, C. Hammerschmidt-Kamper, A. Kretzschmar, E. Fischer, M. Hartmann, P. Schnitzler, H.-G. Kraeusslich, A.-K. Mueller & D. Grimm. "Battle of the midgets - novel insights into the interplay of viruses & pathogens with the host RNAi machinery". Annual meeting of the German Society of Cell Biology (DGZ). Jena, Germany, 2011.
  • D. Niopek, R. Berrens, K. Börner, E. Kienle, R. Eils & D. Grimm (on behalf of the iGEM team Heidelberg 2010). "Synthetic miRNA Switches for Deliberate Fine-tuning of Gene Expression." International Conference of Systems Biology (ICSB). Heidelberg/Mannheim, Germany, 2011.
  • S. Mockenhaupt & D. Grimm. "Alleviation of potentially adverse shRNA off-targeting via AAV-vector encoded sense strand decoys". HBIGS International Summer School on "Regulatory RNAs in physiology, development and disease". Boppard, Germany, 2011
  • D. Niopek & A. Mathur, R. Eils & D. Grimm (on behalf of the iGEM team Heidelberg 2010). "miBricks - DNA is not enough". International genetically engineered machines competition (iGEM). Boston (MA), USA, 2010.
  • S. Mockenhaupt & D. Grimm. "Alleviation of potentially adverse shRNA off-targeting via AAV-vector encoded sense strand decoys". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Washington (DC), USA, 2010.

  • N. Schürmann, E. Wiedtke, G. Meister, L. Wang & D. Grimm. "Directed molecular evolution of chimeric Argonaute proteins as potent new approach to elucidate structure-function relationships of human RISC". Keystone symposium on RNA Silencing: Mechanism, Biology and Application. Keystone (CO), USA, 2010.

National meetings

  • E. Senis & D. Grimm. "Viral vectors and miRNA networks in induced pluripotency." Heidelberg Young Scientist Life Forum. Heidelberg, Germany, 2012.
  • E. Kienle, M. Bechtle & D. Grimm. "Rational AAV capsid engineering via peptide insertion reveals critical roles of the underlying vector serotype". Gene therapy workshop during Annual Meeting of the German Society for Virology. Cologne, Germany, 2011.
Contact: E-Mail (Last update: 21/01/2014)